According to data from MarketBeat, Merck & Co., Inc. currently has an average rating of “Moderate Buy” and a consensus target price of $120.

Source: https://www.etfdailynews.com/2023/06/26/bridge-advisory-llc-has-300000-stock-holdings-in-merck-co-inc-nysemrk/

According to MarketBeat, Merck & Co., Inc. currently has an average rating of “Moderate Buy” and an average target price of $119.

Source: https://www.etfdailynews.com/2023/03/13/engineers-gate-manager-lp-increases-stake-in-merck-co-inc-nysemrk/

According to MarketBeat, Merck & Co., Inc. has an average rating of “Moderate Buy” and an average price target of $123.

Source: https://www.dailypolitical.com/2023/07/28/arrow-financial-corp-sells-221-shares-of-merck-co-inc-nysemrk.html

According to MarketBeat, Merck & Co., Inc. presently has a consensus rating of “Moderate Buy” and an average price target of $119.

Source: https://www.americanbankingnews.com/2023/03/19/accurate-wealth-management-llc-raises-position-in-merck-co-inc-nysemrk.html

According to Merck Manual, the condition often strikes within one to two years of the clot forming inside the vein.

Source: https://www.express.co.uk/life-style/health/1729326/blood-clot-symptoms-postphlebitic-syndrome

Arbor Trust Wealth Advisors LLC lifted its position in shares of Merck & Co., Inc. by 1.9% in the fourth quarter.

Source: https://www.americanbankingnews.com/2023/04/20/dfpg-investments-llc-raises-stock-holdings-in-merck-co-inc-nysemrk.html

As a group, equities research analysts anticipate that Merck & Co., Inc. will post 6.87 EPS for the current fiscal year.

Source: https://www.americanbankingnews.com/2023/03/23/advisornet-financial-inc-decreases-stock-position-in-merck-co-inc-nysemrk.html

As a group, research analysts anticipate that Merck & Co., Inc. will post 3.03 EPS for the current fiscal year.

Source: https://www.dailypolitical.com/2023/09/21/independent-wealth-network-inc-has-375000-stock-holdings-in-merck-co-inc-nysemrk.html

As a group, research analysts expect that Merck & Co., Inc. will post 6.95 EPS for the current year.

Source: https://www.etfdailynews.com/2023/06/26/chartwell-investment-partners-llc-has-27-72-million-stock-position-in-merck-co-inc-nysemrk/

As a group, sell-side analysts forecast that Merck & Co., Inc. will post 1.37 earnings per share for the current year.

Source: https://www.dailypolitical.com/2023/12/11/beutel-goodman-co-ltd-has-257-49-million-stock-holdings-in-merck-co-inc-nysemrk.html

Avitas Wealth Management LLC’s holdings in Merck & Co., Inc. were worth $5,209,000 at the end of the most recent reporting period.

Source: https://www.dailypolitical.com/2023/09/29/merck-co-inc-nysemrk-shares-purchased-by-avitas-wealth-management-llc.html

Avity Investment Management Inc. raised its holdings in Merck & Co., Inc. () by 0.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC.

Source: https://www.americanbankingnews.com/2023/03/21/avity-investment-management-inc-has-1-78-million-stock-position-in-merck-co-inc-nysemrk.html

Bard Financial Services Inc. lowered its stake in shares of Merck & Co., Inc. () by 0.7% during the 1st quarter, according to the company in its most recent filing with the SEC.

Source: https://www.americanbankingnews.com/2023/07/14/bard-financial-services-inc-sells-750-shares-of-merck-co-inc-nysemrk.html

Baystate Wealth Management LLC reduced its position in shares of Merck & Co., Inc. () by 6.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

Source: https://www.dailypolitical.com/2023/12/15/baystate-wealth-management-llc-cuts-stock-holdings-in-merck-co-inc-nysemrk.html

BCK Partners Inc. bought a new position in shares of Merck & Co., Inc. in the 1st quarter worth about $2,423,000.

Source: https://www.etfdailynews.com/2023/06/26/birch-hill-investment-advisors-llc-sells-135805-shares-of-merck-co-inc-nysemrk/

Cantor Fitzgerald Investment Advisor L.P boosted its holdings in Merck & Co., Inc. by 94.2% in the 1st quarter.

Source: https://www.americanbankingnews.com/2023/01/03/crumly-associates-inc-sells-103-shares-of-merck-co-inc-nysemrk.html

Cantor Fitzgerald reissued an “overweight” rating and set a $135.00 price objective on shares of Merck & Co., Inc. in a report on Tuesday, September 5th.

Source: https://www.dailypolitical.com/2023/09/21/hfg-advisors-inc-buys-379-shares-of-merck-co-inc-nysemrk.html

Charles Schwab Investment Management Inc. increased its stake in shares of Merck & Co., Inc. by 3.7% during the 1st quarter.

Source: https://www.americanbankingnews.com/2023/07/16/bergankdv-wealth-management-llc-has-3-22-million-position-in-merck-co-inc-nysemrk.html

Credit Suisse Group upped their price objective on Merck & Co., Inc. from $125.00 to $126.00 and gave the company an “outperform” rating in a report on Tuesday, March 7th.

Source: https://www.americanbankingnews.com/2023/06/22/beese-fulmer-investment-management-inc-has-10-30-million-position-in-merck-co-inc-nysemrk.html

Despite this, he believes the pharma industry in Ireland is “absolutely” stable, citing the expansion announced by Merck last year, who claim they will create 235 jobs at new facilities in Blarney and 135 new jobs in Carrigtwohill by 2027.

Source: https://www.independent.ie/regionals/cork/news/optimism-in-cork-town-despite-news-of-job-losses/a724737258.html